CClinicalTrials.gg
RecruitingNCT06561165Updated Feb 17, 2026

Multifocal HD-tDCS and Motor Function

An interventional study of Standard HD-tDCS intervention and Multifocal network targeted HD-tDCS intervention in Healthy, sponsored by University of Michigan. Recruiting at 1 site in United States. Open to participants aged 65 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-17.

Sponsored by University of Michigan · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
65 Years to 85 Years
Sex
All
01

Study summary

The purpose of this study is to understand how the brain controls movement and how Non-invasive Brain Stimulation (NIBS) with a technique called High-density transcranial direct current stimulation (HD-tDCS) can alter brain processes to improve behavior. Participants in this study will be randomized to either HD-tDCS with standard intervention or personalized dose-controlled multifocal network-targeted HD-tDCS.

The hypothesis is that dexterous hand function will improve after a standard HD-tDCS dose and increase even more after personalized dose-controlled multifocal network-targeted HD-tDCS.

Read the detailed description

This project is the first of two projects. The second project will be registered as a separate project in the future and enroll participants from this project.

02

Conditions studied

  • Healthy

Keywords

  • Functional Magnetic Resonance Imaging (fMRI)
  • High-density transcranial direct current stimulation
  • manual dexterity
  • Non-invasive brain stimulation
03

In context

Lead sponsor

University of Michigan is the lead sponsor of 1,476 studies on the registry; 197 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants should be in good health with normal or corrected-to-normal visual acuity
  • Right handed
  • No history of neurological disorder
  • English speaker
  • Able to provide written consent prior to admission

Exclusion criteria

Exclusion Criteria:

  • Left-handed
  • Participants are pregnant, suspect pregnancy or are attempting to become pregnant
  • Have a pacemaker, intracardiac lines or any other medically implanted device or medicine pump
  • Have cochlear hearing implants
  • Taking drugs known to influence neural receptors that facilitate neuroplasticity (see protocol)
  • Have non removable body piercings or have foreign objects in body
  • Have metal anywhere in the head that could increase risk of serious injury (not including braces, dental fillings, etc.) (see protocol)
  • Have a personal or family history of seizure/epilepsy
  • Taking prescription drugs that lower the threshold for seizures
  • Recent history of excessive alcohol consumption
  • History of alcohol addiction/dependence
  • Recent history of recreational drug use
  • History of drug addiction/dependence
  • Recent history of recreational drug use
  • History of drug addiction/dependence
  • Diagnosed with a stroke, brain hemorrhage, brain tumor, encephalitis.
  • Diagnosed with multiple sclerosis
  • Diagnosed with Parkinson's disease or Alzheimer's disease
  • Diagnosed with depression in the past 6 months
  • Diagnosed with attention deficit disorder, schizophrenia, manic depressive (bipolar) disorder
  • Diagnosed with normal pressure hydrocephalus or increased intra-cranial pressure
  • Diabetes requiring insulin treatment
  • Any serious heart disorder or liver disease
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    HD-tDCS with standard intervention

    Participants will have three daily sessions.

    Device: Standard HD-tDCS intervention · Device: Functional Magnetic Resonance Imaging (fMRI)

  • Experimental
    Personalized dose-controlled multifocal network-targeted HD-tDCS.

    Participants will have three daily sessions.

    Device: Multifocal network targeted HD-tDCS intervention · Device: Functional Magnetic Resonance Imaging (fMRI)

Interventions

  • DeviceStandard HD-tDCS intervention

    Participants will have three sessions along with behavioral assessments.

  • DeviceMultifocal network targeted HD-tDCS intervention

    Participants will have three sessions along with behavioral assessments.

  • DeviceFunctional Magnetic Resonance Imaging (fMRI)

    Participants will have an MRI before or after having HD-tDCS intervention.

06

What researchers measure

Primary outcomes

  1. Percent change in precision force-tracking task

    Squared distance (error) from the cursor to the target in precision force-tracking task, estimated as the root mean squared error (RMSE).

    Time frame: Baseline and 24 hours after the third sessions are completed

  2. Percentage change in the time to complete the nine-hole peg test (9-HPT)

    9-hole peg test is a manual dexterity measure, estimated as the time required to complete the task (seconds).

    Time frame: Baseline and 24 hours after the third sessions are completed

Secondary outcomes

  1. Percentage change in the mean choice reaction time

    Mean reaction time for subjects responding in the 2-choice reaction time control task, for correct responses

    Time frame: Baseline and 24 hours after the third sessions are completed

07

Study locations

1 of 1 sites recruiting
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
    • Michael Vesia, PhD · Contact · mvesia@umich.edu · 734-764-5237
    • Michael Vesia, PhD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06561165
Lead sponsor
University of Michigan
Collaborators
Medical University of South Carolina, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Responsible party
Michael Vesia, PhD (Assistant Professor of Kinesiology, University of Michigan) — Principal investigator
First posted
Aug 19, 2024
Start date
Feb 25, 2025
Primary completion
Jan 25, 2027 (estimated)
Completion
Jan 25, 2027 (estimated)
Last update
Feb 17, 2026

Study contacts

Michael Vesia, PhD
Contact
mvesia@umich.edu
734-764-5237
Michael Vesia, PhD
principal investigator · University of Michigan

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion